Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Millard

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Current Medical Research and Opinion|April 18, 2008
24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint painKristine L Clark, Wayne Sebastianelli, Klaus R Flechsenhar, et al.
IEEE Transactions on Bio-Medical Engineering|December 28, 2016
Wearable Vector Electrical Bioimpedance System to Assess Knee Joint HealthSinan Hersek, Hakan Toreyin, Caitlin N Teague, et al.
The Journal of Biological Chemistry|December 23, 2008
Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analoguesEmma L Millard, Simon T Nevin, Marion L Loughnan, et al.
Science (New York, N.Y.)|August 21, 2010
Science education. Partnerships for STEM educationK M Foster, K B Bergin, A F McKenna, et al.
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.
Gastroenterology Research and Practice|January 4, 2011
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic FibrosisMichael W Konstan, Theodore G Liou, Steven D Strausbaugh, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 15, 2024
Self-reported chronic therapy use after 24-weeks of follow-up by participants who completed the simplify randomized, controlled trialAlex H Gifford, Katherine Odem-Davis, Margaret Kloster, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2018
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1Joshua F Apgar, Jian-Ping Tang, Pratap Singh, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 19, 2020
CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1J F Apgar, J P Tang, P Singh, et al.
Human Genetics|August 1, 2020
Genomic, transcriptomic, and protein landscape profile of CFTR and cystic fibrosisMorgan Sanders, James M J Lawlor, Xiaopeng Li, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Current Medical Research and Opinion|April 18, 2008
24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint painKristine L Clark, Wayne Sebastianelli, Klaus R Flechsenhar, et al.
IEEE Transactions on Bio-Medical Engineering|December 28, 2016
Wearable Vector Electrical Bioimpedance System to Assess Knee Joint HealthSinan Hersek, Hakan Toreyin, Caitlin N Teague, et al.
The Journal of Biological Chemistry|December 23, 2008
Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analoguesEmma L Millard, Simon T Nevin, Marion L Loughnan, et al.
Science (New York, N.Y.)|August 21, 2010
Science education. Partnerships for STEM educationK M Foster, K B Bergin, A F McKenna, et al.
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.
Gastroenterology Research and Practice|January 4, 2011
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic FibrosisMichael W Konstan, Theodore G Liou, Steven D Strausbaugh, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 15, 2024
Self-reported chronic therapy use after 24-weeks of follow-up by participants who completed the simplify randomized, controlled trialAlex H Gifford, Katherine Odem-Davis, Margaret Kloster, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2018
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1Joshua F Apgar, Jian-Ping Tang, Pratap Singh, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 19, 2020
CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1J F Apgar, J P Tang, P Singh, et al.
Human Genetics|August 1, 2020
Genomic, transcriptomic, and protein landscape profile of CFTR and cystic fibrosisMorgan Sanders, James M J Lawlor, Xiaopeng Li, et al.
Pageof 11